Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Wedbush Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $36
Express News | Cullinan Therapeutics Receives Approval to Initiate Its Global Phase 1 Clinical Trial of Cln-978
TD Cowen Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating
Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $40
Express News | Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for Cln-978 to Treat Systemic Lupus Erythematosus
H.C. Wainwright Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $28
Cullinan Oncology Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
Cullinan Therapeutics Presents Positive Updated Data From Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024
BTIG Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $30
JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $29
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
We Think Cullinan Therapeutics (NASDAQ:CGEM) Can Afford To Drive Business Growth
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
Express News | Wedbush Reiterates Outperform on Cullinan Therapeutics, Maintains $36 Price Target
Cullinan Therapeutics Analyst Ratings
Express News | Cullinan Therapeutics : Morgan Stanley Cuts Target Price to $38.00 From $40.00
Express News | Cullinan Therapeutics Cash, Cash Equivalents, Investments, And Interest Receivable Were $664.9M As Of June 30, 2024. Cullinan Continues To Expect Its Cash Resources To Provide Runway Into 2028 Based On Its Current Operating Plan
Express News | Cullinan Therapeutics Q2 2024 GAAP EPS $(0.75) Misses $(0.73) Estimate
HBM Holdings Ends Deal With Cullinan Therapeutics